These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7931465)

  • 1. Angiotensin converting enzyme inhibitors: inhibition of growth, a novel mechanism of action.
    Fish AF
    J Cardiovasc Nurs; 1994 Jul; 8(4):57-71. PubMed ID: 7931465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
    Farhy RD; Carretero OA; Ho KL; Scicli AG
    Circ Res; 1993 Jun; 72(6):1202-10. PubMed ID: 7684331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease?
    Ruschitzka FT; Lüscher TF
    Am Heart J; 1997 Aug; 134(2 Pt 2):S31-47. PubMed ID: 9313622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of cardiac function by angiotensin converting enzyme inhibition. Sites of action.
    Dietz R; Waas W; Süsselbeck T; Willenbrock R; Osterziel KJ
    Circulation; 1993 May; 87(5 Suppl):IV108-16. PubMed ID: 8485825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the pharmacological differences observed between angiotensin II antagonists and inhibitors of angiotensin converting enzyme be clinically beneficial?
    Levens NR; de Gasparo M; Wood JM; Bottari SP
    Pharmacol Toxicol; 1992 Oct; 71(4):241-9. PubMed ID: 1454748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme and vascular remodeling.
    Heeneman S; Sluimer JC; Daemen MJ
    Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and vascular hypertrophy.
    Rosendorff C
    J Am Coll Cardiol; 1996 Oct; 28(4):803-12. PubMed ID: 8837552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
    Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
    Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
    Dzau VJ
    Basic Res Cardiol; 1993; 88 Suppl 1():1-14. PubMed ID: 8395169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
    Sesin J; Tamargo J
    Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of neointima by angiotensin-converting enzyme inhibitor in porcine coronary artery balloon-injury model.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Aoki M; Sakonjo H; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 2001 Feb; 37(2):270-4. PubMed ID: 11230284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
    Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin, ACE-inhibitors and endothelial control of vasomotor tone.
    Lüscher TF
    Basic Res Cardiol; 1993; 88 Suppl 1():15-24. PubMed ID: 8357330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation.
    Rakugi H; Wang DS; Dzau VJ; Pratt RE
    Circulation; 1994 Jul; 90(1):449-55. PubMed ID: 7517799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiology patient page. What is an angiotensin converting enzyme inhibitor?
    Sweitzer NK
    Circulation; 2003 Jul; 108(3):e16-8. PubMed ID: 12876137
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular hypertrophy: role of angiotensin II and bradykinin.
    Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 2():S36-40. PubMed ID: 8723398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular renin-angiotensin system and vascular protection.
    Dzau VJ
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S1-9. PubMed ID: 7508045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of aortic wall structure by the renin-angiotensin system in Wistar rats.
    Unkelbach M; Auch-Schwelk W; Unkelbach E; Jautzke G; Fleck E
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):31-8. PubMed ID: 9456274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system.
    Pratt RE; Dzau VJ
    Circulation; 1996 Mar; 93(5):848-52. PubMed ID: 8598073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.